119
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Intravenous Iron Isomaltoside 1000 Reduces Postoperative Anemia in Patients Undergoing Elective Urologic Surgery and Those with Urosepsis

ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 5679-5687 | Published online: 23 Dec 2020

References

  • VincentJL, BaronJF, ReinhartK, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499–1507.12243637
  • ViljoenM, CoetzeeIH, RouxLJ, et al. Anemia in surgical intensive care patients. Haematologica. 1994;79(1):19–24.15378944
  • KarkoutiK, WijeysunderaDN, BeattieWS. the Reducing Bleeding in Cardiac surgery (RBC) investigators. Risk associated with preoperative anemia in cardiac surgery: a multicentre cohort study. Circulation. 2008;117(4):478–484. doi:10.1161/CIRCULATIONAHA.107.71835318172032
  • Van StratenAHM, HamadMA, van ZundertAJ, et al. Preoperative Hemoglobin level as a predictor of survival after coronary artery bypass grafting. Circulation. 2009;120(2):118–125. doi:10.1161/CIRCULATIONAHA.109.85421619564556
  • BeattieWS, KarkoutiK, WijeysunderaDN, et al. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology. 2009;110:574–581.19212255
  • HotchkissRS, KarlIE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–150. doi:10.1056/NEJMra02133312519925
  • JelkmannW. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18(8):555–559. doi:10.1089/jir.1998.18.5559726435
  • RiversE, NguyenB, HavstadS, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. doi:10.1056/NEJMoa01030711794169
  • DunneJR, MaloneD, TracyJK, et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res. 2002;102(2):237–244. doi:10.1006/jsre.2001.633011796024
  • BernardAC, DavenportDL, ChangPK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208(5):931–937. doi:10.1016/j.jamcollsurg.2008.11.01919476865
  • MunozM, Gomez-RamirezS, CuencaJ, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289–299.23581484
  • KochCG, LiL, Van WagonerDR, et al. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82(5):1747–1756. doi:10.1016/j.athoracsur.2006.05.04517062241
  • TheusingerOM, FelixC, SpahnDR. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol. 2012;25(1):59–65. doi:10.1097/ACO.0b013e32834dec9822113184
  • SilverbergDS, IainaA, PeerG, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis. 1996;27(2):234–238. doi:10.1016/S0272-6386(96)90546-68659499
  • AltmanLC, PetersenPE. Successful prevention of an anaphylactoid reaction to iron dextran. Ann Intern Med. 1988;109:346–347. doi:10.7326/0003-4819-109-4-3462456030
  • JahnMR, AndreasenHB, F€uttererS, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm. 2011;78:480–491. doi:10.1016/j.ejpb.2011.03.01621439379
  • BhandariS, KalraPA, KothariJ, et al. A randomized, open-label trial of iron isomaltoside 1000 (MonoferVR) compared with iron sucrose (VenoferVR) as maintenance therapy in haemodialysis patients. Nephrol Dial Transplant. 2015;30:1577–1589. doi:10.1093/ndt/gfv09625925701
  • ReinischW, AltorjayI, ZsigmondF, et al. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol. 2015;50(10):1226–1233. doi:10.3109/00365521.2015.103116825900645
  • DahlerupJ, LindgrenS. High dose intravenous iron isomaltoside 1000 in patients with inflammatory bowel disease – the PROMISE trial. Poster presented at 10th Congress of the European Crohn’s and Colitis Organisation (ECCO), February 8–21; 2015; Barcelona, Spain.
  • JohanssonPI, RasmussenAS, ThomsenLL. Intravenous iron isomaltoside 1000 (MonoferVR) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109:257–266.25900643
  • FroesslerB, PalmP, WeberI, et al. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41–46. doi:10.1097/SLA.000000000000164626817624
  • AvniT, BieberA, GrossmanA, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1):12–23. doi:10.1016/j.mayocp.2014.10.00725572192
  • RognoniC, VenturiniS, MeregagliaM, et al. Efficacy and safety of ferric carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomised controlled trials. Clin Drug Investig. 2016;36(3):177–194. doi:10.1007/s40261-015-0361-z
  • GoodnoughLT, ShanderA, SpivakJL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg. 2005;101:1858–1861. doi:10.1213/01.ANE.0000184124.29397.EB16301274
  • ShanderA, KnightK, ThurerR, et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):58S–69S. doi:10.1016/j.amjmed.2003.12.01315050887
  • TheusingerOM, LeyvrazP-F, SchanzU, et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology. 2007;107(6):923–927. doi:10.1097/01.anes.0000291441.10704.8218043060
  • DellingerRP, CarletJM, MasurH, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–873. doi:10.1097/01.CCM.0000117317.18092.E415090974
  • IbrahimEH, ShermanG, WardS, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118(1):146–155. doi:10.1378/chest.118.1.14610893372
  • DregerNM, DegenerS, Ahmad-NejadP, et al. Urosepsis–etiology, diagnosis, and treatment. Dtsch Arztebl Int. 2015;112:837–847.26754121
  • EdwardsTJ, NobleEJ, DurranA, et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br J Surg. 2009;96(10):1122–1128. doi:10.1002/bjs.668819731228
  • Garrido-MartínP, Nassar-MansurMI, de la Llana-ducrósR, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg. 2012;15(6):1013–1018. doi:10.1093/icvts/ivs34422940889
  • Serrano-TrenasJA, UgaldePF, CabelloLM, et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion. 2011;51(1):97–104. doi:10.1111/j.1537-2995.2010.02769.x20630042